<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Discovery Bit | Issla Fisher | Activity</title>
	<link>https://www.discoverybit.com/members/lilykrimmer356/activity/</link>
	<atom:link href="https://www.discoverybit.com/members/lilykrimmer356/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Issla Fisher.</description>
	<lastBuildDate>Wed, 29 Jul 2026 09:52:59 -0600</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">72dfe5bbc0e44d3b19747372b5d8ed49</guid>
				<title>Issla Fisher posted an update in the group Product: The US FDA Has Approved The First Long-Acting Injectable HIV [&#133;]</title>
				<link>https://www.discoverybit.com/activity/p/42441/</link>
				<pubDate>Mon, 27 Dec 2021 03:42:21 -0600</pubDate>

									<content:encoded><![CDATA[<p>The US FDA Has Approved The First Long-Acting Injectable HIV PrEP Medication. The Drug, Called Apretude, Given To Patients Every 2 Months, Is Said To Be 69% More Effective Than The Daily HIV Prevention Pills, Like <a href="//www.discoverybit.com/activity/p/35872/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank">Truvada</a> and Descovy, For Cisgender Men And Transgender Women Who Have Sex With Men, And 90% More Effective For Cisgender Women. </p>
<div class="bpfb_final_link">
<div class="bpfb_link_preview_container">
		<a href="https://www.nbcnews.com/nbc-out/out-health-and-wellness/fda-approves-first-injectable-hiv-prevention-drug-rcna9426" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"><img loading="lazy" src="https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2021-12/211220-glaxosmith-kline-jm-1823-f1eed0.jpg" /></a>&hellip;</div>
</div>
<p><span class="activity-read-more" id="activity-read-more-42441"><a href="https://www.discoverybit.com/activity/p/42441/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"></a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f543b56387736784132f847060e6b911</guid>
				<title>Issla Fisher posted an update in the group Health: Victoria Gray, Age 34, The First Person Treated In The USA [&#133;]</title>
				<link>https://www.discoverybit.com/activity/p/36410/</link>
				<pubDate>Fri, 26 Jun 2020 22:54:45 -0600</pubDate>

									<content:encoded><![CDATA[<p>Victoria Gray, Age 34, The First Person Treated In The USA With The Gene-Editing Tool Called <a href="https://www.discoverybit.com/activity/p/35816/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"> CRISPR,</a> Is Showing Positive Signs A Year After  Her Treatment, Which Comprises Infusing Billions Of Genetically Modified Cells Into Her Body By Doctors. This Appears To Be Alleviating Virtually All Complications Of Her Sickle Cell Disease Disorder. </p>
<div class="bpfb_final_link">
<div class="bpfb_link_preview_container">
		<a href="https://www.npr.org/sections/health-shots/2020/06/23/877543610/a-year-in-1st-patient-to-get-gene-editing-for-sickle-cell-disease-is-thriving" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"><img loading="lazy" src="https://media.npr.org/assets/img/2020/06/19/gray-family_wide-ed7dab110d09aeae917324cf886e74aac0cc6b99.jpg?s=1400" /></a>&hellip;</div>
</div>
<p><span class="activity-read-more" id="activity-read-more-36410"><a href="https://www.discoverybit.com/activity/p/36410/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"></a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8f85ad2e564a54516730a0168e4b553f</guid>
				<title>Issla Fisher posted an update in the group Health: A New Drug Implant, Designed To Prevent HIV  Infection In [&#133;]</title>
				<link>https://www.discoverybit.com/activity/p/35872/</link>
				<pubDate>Wed, 24 Jul 2019 20:26:38 -0600</pubDate>

									<content:encoded><![CDATA[<p>A New Drug Implant, Designed To Prevent <a href="//www.discoverybit.com/activity/p/35816/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank">HIV </a> Infection In High-Risk People Like The Gays,  Has Been Developed. The Drug, 10x More Potent Than Any Antiretroviral Medication, Works By Providing Continuous Dose High Enough To Shield Against HIV For A Year, Overcoming Limitations Of Adhering To The Once/Day Pill Regimen Of Truvada. </p>
<div class="bpfb_final_link">
<div class="bpfb_link_preview_container">
		<a href="https://khn.org/morning-breakout/matchstick-size-implant-with-new-drug-may-protect-against-hiv-infection-it-could-be-a-game-changer/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"><img loading="lazy" src="https://khn.org/wp-content/themes/kaiser-healthnews-2017/static/images/placeholder.jpg" /></a>
	</div>
<div class="bpfb_link_contents">
<div class="bpfb_link_preview_title">Matchs&hellip;</div>
</div>
</div>
<p><span class="activity-read-more" id="activity-read-more-35872"><a href="https://www.discoverybit.com/activity/p/35872/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"></a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">05ef6d92c032687833efddfed9a998d6</guid>
				<title>Issla Fisher posted an update in the group Health: Researchers, Using Genome Editing Tool, CRISPR-Cas9, Coupled [&#133;]</title>
				<link>https://www.discoverybit.com/activity/p/35816/</link>
				<pubDate>Thu, 04 Jul 2019 01:09:20 -0600</pubDate>

									<content:encoded><![CDATA[<p>Researchers, Using Genome Editing Tool, CRISPR-Cas9, Coupled With The Use Of Long-Acting, Slow-Effective Release <a href="//www.discoverybit.com/activity/p/35616/" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank">ART,</a>  Which Can Suppress HIV Cells From Replicating, Were Able To Completely Eliminate HIV In 9 Out Of 23 Mice.  This Result, In Mice, May Herald The Complete Elimination Of HIV In Human. Cool!  </p>
<div class="bpfb_final_link">
<div class="bpfb_link_preview_container">
		<a href="https://www.cnn.com/2019/07/02/us/researchers-eliminated-hiv-from-mice-dna-trnd/index.html" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"><img loading="lazy" src="https://cdn.cnn.com/cnnnext/dam/assets/151030155423-pioneers-crispr-dna-gene-editing-super-tease.jpg" /></a>
	</div>
<div class="bpfb_link_contents">
<div class="bpfb_link_preview_title"></div>
<div class="bpfb_link_preview_url">
			<a href="https://www.cnn.com/2019/07/02/us/researchers-eliminated-hiv-from-mice-dna-trnd/index.html" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank"></a><a href="https://www.cnn.com/2&#038;hellip" rel="ugc nofollow external noopener noreferrer" data-wpel-link="external" target="_blank">https://www.cnn.com/2&#038;hellip</a>;</div>
</div>
</div>
<p><span class="activity-read-more" id="activity-read-more-35816"><a href="https://www.discoverybit.com/activity/p/35816/" rel="ugc follow noopener noreferrer" data-wpel-link="internal" target="_self"></a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>